Vol. 2 No. 1 (2019): Stockholm Intellectual Property Law Review

DOI: https://doi.org/10.59625/siplr.v2i1

Published: 2026-01-12

Full Issue

• Full Issue PDF

Editorial

• Editorial Preface

  Frantzeska Papadopoulou, Åsa Hellstadius

  2 - 3

  • PDF

Original Articles

• Evergreening and patent cliff hangers

  Prof. Ove Granstrand

  4 - 11

  • PDF

• CRISPR/Cas9 system and gene editing tools On patent rights, recent disputes and its potential commercial applicability in biotechnology and medicine

  Thomas Hedner, Jean Lycke

  12 - 23

  • PDF

• Being equitable about equivalents

  John Hornby

  24 - 37

  • PDF

• Second medical use claims and scope of protection A work in progress since 1984

  Clara Berrisch

  38 - 47

  • PDF

• Do rules experience culture shock? Interpreting Article 3(a) of the Supplementary Protection Certificate Regulation: is the donor rule faulty or is the transplanted rule incompatible with its new legal environment?

  Lisa West Åkerblom

  48 - 59

  • PDF

• The patentability of Dosage Regimes How to receive and enforce Dosage Regimes patents in Europe

  Ester-Maria Elze

  60 - 75

  • PDF

• Safeguarding public health in the wake of hegemonic intellectual property rights – Two means to this end?

  Katarina Foss-Solbrekk

  76 - 93

  • PDF

• In Pursuit of Robinson Crusoe: Pharmaceutical Naming from the Lab to the Pharmacy

  Kristina Björnerstedt, Gunnel Nilsson

  94 - 97

  • PDF

Case Notes

• The CJEU clarifies the effects of skinny labelling What uncertainties remain from a Swedish perspective?

  Sofia Bergenstråhle, Valter Gran

  98 - 101

  • PDF